Skip to main navigation Skip to search Skip to main content

Docking to erlotinib off-targets leads to inhibitors of lung cancer cell proliferation with suitable in vitro pharmacokinetics

  • Liwei Li
  • , Jing Li
  • , May Khanna
  • , Inha Jo
  • , Jason P. Baird
  • , Samy O. Meroueh

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Docking to erlotinib off-targets leads to inhibitors of lung cancer cell proliferation with suitable in vitro pharmacokinetics'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science